Fundraising Fox
Totus Medicines
27 employees on LinkedIn · 3 known investors
Find your way into Totus Medicines
Sign up to see every warm intro you have to Totus Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Totus Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
Founders & leadership
Investors · 3
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BDec 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Totus Medicines do?
- Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
- Who founded Totus Medicines?
- Totus Medicines was founded by Neil Dhawan, PhD.
- Who are Totus Medicines's investors?
- Totus Medicines's investors include DCVC (Data Collective), DCVC Bio, Social Impact Capital.